Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries.
暂无分享,去创建一个
[1] J. Connell,et al. Vasoconstrictor Effect of the Angiotensin-Converting Enzyme–Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans , 2001, Circulation.
[2] G. Ferry,et al. Functional Evidence for a Role of Vascular Chymase in the Production of Angiotensin II in Isolated Human Arteries , 2001, Circulation.
[3] J. Connell,et al. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. , 2001, Journal of the American College of Cardiology.
[4] M. Amrani,et al. Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery. , 2000, The Annals of thoracic surgery.
[5] AH Chester,et al. Chymase-dependent angiotensin II formation in human blood vessels , 2000, Journal of Human Hypertension.
[6] K. Fujii,et al. Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT). , 1999, American heart journal.
[7] A. Danser,et al. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. , 1999, Cardiovascular research.
[8] A. Tessitore,et al. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. , 1999, Circulation.
[9] L. Ruilope,et al. AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. , 1999, Hypertension.
[10] J. Connell,et al. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries. , 1999, Circulation.
[11] D. Harrison,et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.
[12] S. Takai,et al. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. , 1999, Circulation.
[13] Y. Pinto,et al. Dual pathway for angiotensin II formation in human internal mammary arteries , 1998, British journal of pharmacology.
[14] M. Yacoub,et al. Alternative pathways of angiotensin II production in the human saphenous vein , 1998, British journal of pharmacology.
[15] K. Andersson,et al. Conversion of Angiotensin I to Angiotensin II by Chymase Activity in Human Pulmonary Membranes , 1997, Peptides.
[16] W. Kiowski,et al. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. , 1997, Circulation research.
[17] K. Miyazawa,et al. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. , 1995, Atherosclerosis.
[18] J. Ménard,et al. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. , 1995, Circulation.
[19] Hiroaki Tanaka,et al. Angiotensin II formation by an alternative pathway during exercise in humans , 1994, Journal of hypertension.
[20] L. Nilsson,et al. Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle. , 1994, The American journal of physiology.
[21] K. Tanaka,et al. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. , 1994, Atherosclerosis.
[22] A. Koda,et al. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. , 1993, Japanese journal of pharmacology.
[23] Lippincott Williams Wilkins,et al. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angiopla , 1992, Circulation.
[24] H. Baumgartner,et al. Role of Angiotensin II in Injury‐Induced Neointima Formation in Rats , 1991, Hypertension.
[25] S. Roux,et al. Cilazapril Inhibits Wall Thickening of Vein Bypass Graft in the Rat , 1991, Hypertension.
[26] R. Graham,et al. Cloning of the gene and cDNA for human heart chymase. , 1991, The Journal of biological chemistry.
[27] F. Soubrier,et al. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. , 1991, The Journal of biological chemistry.
[28] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[29] K. Misono,et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. , 1990, The Journal of biological chemistry.
[30] B. Healy,et al. Angiotensin II-forming pathways in normal and failing human hearts. , 1990, Circulation research.
[31] A. Chobanian,et al. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. , 1990, Hypertension.
[32] M. Miyazaki,et al. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. , 1987, Biochemical and biophysical research communications.
[33] B. Wílkes,et al. Plasma Angiotensins and Blood Pressure During Converting Enzyme Inhibition , 1987, Hypertension.
[34] L. Kedes,et al. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. , 1984, Nucleic acids research.
[35] M. Mulvany,et al. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. , 1977, Circulation research.